A Phase 1, Open-Label Study to Examine the Effect of Ciprofloxacin, Itraconazole, and Rifampin on the Pharmacokinetics of Lumacaftor in Combination With Ivacaftor in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 14 Nov 2013
Price : $35 *
At a glance
- Drugs Ivacaftor (Primary) ; Lumacaftor (Primary) ; Ciprofloxacin; Itraconazole; Rifampicin
- Indications Bacterial infections; Cystic fibrosis
- Focus Pharmacokinetics; Therapeutic Use
- 14 Nov 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 24 Jul 2013 Planned number of patients changed from 54 to 78 as reported by ClinicalTrials.gov record.